Investigators at University of California, Berkeley have developed hybridoma lines (MRY909 and 10A3) that express mouse monoclonal antibodies against mouse CTLA-4. These mouse antibodies should have longer half-life and be more potent in in vitro systems than previously available antibodies of hamster origin.
Series of mouse antibodies with increased stability for testing in mice.
antibody, research tool, reagent